Skip to main content

Table 5 Comparison of CRT at each visit

From: Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial

CRT (μm)

IVR group (n = 44)

IVC group (n = 46)

P value

Baseline

313.89 ± 122.97

314.61 ± 108.01

0.976

Postoperative 1 week

245.25 ± 61.98

250.09 ± 56.43

0.699

Postoperative 1 month

227.23 ± 42.37

232.39 ± 39.52

0.551

Postoperative 3 months

222.59 ± 36.52

225.63 ± 34.48

0.686

  1. CRT = central retinal thickness; IVR = intravitreal ranibizumab; IVC = intravitreal conbercept
Back to article page

Eye and Vision

ISSN: 2326-0254